NCT01262612 2013-07-15
Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion
Radboud University Medical Center
Phase 2 Terminated
Radboud University Medical Center
National Cancer Institute (NCI)
AstraZeneca